Evidence map›Paper›PMID 37589995›Full record

ArticleJAMA ophthalmology2023

Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden.

Sayuri Sekimitsu, David Xiang, Sophie Lloyd Smith, Katie Curran, Tobias Elze, David S Friedman, Paul J Foster, Yuyang Luo, Louis R Pasquale, Tunde Peto and 7 more

Open access · greenAbstract read
In one paragraph

Article in JAMA ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Uptake of Polygenic Risk Testing for Glaucoma in Unaffected Individuals.Translational vision science & technology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Sayuri SekimitsuTufts University School of Medicine, Boston, Massachusetts.
David XiangDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Sophie Lloyd SmithTufts University School of Medicine, Boston, Massachusetts.
Katie CurranCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Tobias ElzeSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
David S FriedmanDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Paul J FosterNIHR Biomedical Research Centre, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom.
Yuyang LuoDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Louis R PasqualeIcahn School of Medicine at Mount Sinai, Department of Ophthalmology, New York, New York.
Tunde PetoCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Ayellet V SegrèDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Yusrah ShweikhSussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Sussex, United Kingdom.
Alasdair WarwickUniversity College London, Institute of Cardiovascular Science, London, United Kingdom.
Yan ZhaoDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Janey L WiggsDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Nazlee ZebardastDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
UK Biobank Eye and Vision Consortium
UK Biobank · GBMassachusetts Eye and Ear Infirmary · USQueen's University Belfast · GBTufts University · USIcahn School of Medicine at Mount Sinai · USMoorfields Eye Hospital NHS Foundation Trust · GBSussex Eye Hospital · GB

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
P30 Core Grant for Vision ResearchP30EY014104 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Janey L Wiggs · 2002 to 2026
$15.1M
Understanding the clinical impact of cumulative genetic risk to glaucomaR01EY032559 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Louis Robert Pasquale, Janey L Wiggs · 2021 to 2026
$4.3M
NEI NIH HHS P30 EY003790NEI NIH HHS P30 EY014104NEI NIH HHS R01 EY032559
6 · The paper itself

Abstract

Importance: Better understanding of primary open-angle glaucoma (POAG) genetics could enable timely screening and promote individualized disease risk prognostication. Objective: To evaluate phenotypic features across genetic burden for POAG. Design, Setting, and Participants: This was a cross-sectional, population-based study conducted from 2006 to 2010. Included participants were individuals from the UK Biobank aged 40 to 69 years. Individuals with non-POAG forms of glaucoma were excluded from the analysis. Data were statistically analyzed from October 2022 to January 2023. Main Outcomes and Measures: POAG prevalence based on structural coding, self-reports, and glaucoma-related traits. Results: Among 407 667 participants (mean [SD] age, 56.3 [8.1] years; 219 183 majority sex [53.8%]) were 14 171 POAG cases. Area under receiver operating characteristic curve for POAG detection was 0.748 in a model including polygenic risk score (PRS), age, sex, and ancestry. POAG prevalence in the highest decile of PRS was 7.4% (3005 of 40 644) vs 1.3% (544 of 40 795) in lowest decile (P < .001). A 1-SD increase in PRS was associated with 1.74 times higher odds of POAG (95% CI, 1.71-1.77), a 0.61-mm Hg increase in corneal-compensated intraocular pressure (IOP; 95% CI, 0.59-0.64), a -0.09-mm Hg decrease in corneal hysteresis (95% CI, -0.10 to -0.08), a 0.08-mm Hg increase in corneal resistance factor (95% CI, 0.06-0.09), and a -0.08-diopter decrease in spherical equivalent (95% CI, -0.11 to -0.07; P < .001 for all). A 1-SD increase in PRS was associated with a thinning of the macula-region retinal nerve fiber layer (mRNFL) of 0.14 μm and macular ganglion cell complex (GCC) of 0.26 μm (P < .001 for both). In the subset of individuals with fundus photographs, a 1-SD increase in PRS was associated with 1.42 times higher odds of suspicious optic disc features (95% CI, 1.19-1.69) and a 0.013 increase in cup-disc ratio (CDR; 95% CI, 0.012-0.014; P < .001 for both). A total of 22 of 5193 fundus photographs (0.4%) in decile 10 had disc hemorrhages, and 27 of 5257 (0.5%) had suspicious optic disc features compared with 9 of 5158 (0.2%) and 10 of 5219 (0.2%), respectively, in decile 1 (P < .001 for both). CDR in decile 10 was 0.46 compared with 0.41 in decile 1 (P < .001). Conclusion and Relevance: Results suggest that PRS identified a group of individuals at substantially higher risk for POAG. Higher genetic risk was associated with more advanced disease, namely higher CDR and corneal-compensated IOP, thinner mRNFL, and thinner GCC. Associations with POAG PRS and corneal hysteresis and greater prevalence of disc hemorrhages were identified. These results suggest that genetic risk is an increasingly important parameter for risk stratification to consider in clinical practice.

Indexed as

GlaucomaGlaucoma, Open-AngleCorneaCross-Sectional StudiesHemorrhageHumansMiddle Aged

Identifiers

PMID37589995
PMCPMC10436188
OpenAlexW4385897449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.